UK markets close in 4 hours 9 minutes

Hims & Hers Health, Inc. (HIMS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
12.34+0.01 (+0.08%)
At close: 04:00PM EDT
12.35 +0.01 (+0.08%)
Pre-market: 07:01AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.64B
Enterprise value 2.43B
Trailing P/E N/A
Forward P/E 204.08
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.96
Price/book (mrq)7.68
Enterprise value/revenue 2.79
Enterprise value/EBITDA -122.02

Trading information

Stock price history

Beta (5Y monthly) 0.91
52-week change 36.93%
S&P500 52-week change 322.64%
52-week high 317.16
52-week low 35.65
50-day moving average 313.53
200-day moving average 39.13

Share statistics

Avg vol (3-month) 35.11M
Avg vol (10-day) 34.33M
Shares outstanding 5205.87M
Implied shares outstanding 6214.25M
Float 8172.45M
% held by insiders 111.76%
% held by institutions 161.80%
Shares short (15 Apr 2024) 417.47M
Short ratio (15 Apr 2024) 43.58
Short % of float (15 Apr 2024) 410.93%
Short % of shares outstanding (15 Apr 2024) 48.15%
Shares short (prior month 15 Mar 2024) 412.76M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -2.70%
Operating margin (ttm)1.06%

Management effectiveness

Return on assets (ttm)-4.03%
Return on equity (ttm)-7.18%

Income statement

Revenue (ttm)872M
Revenue per share (ttm)4.16
Quarterly revenue growth (yoy)47.50%
Gross profit (ttm)N/A
EBITDA -16.49M
Net income avi to common (ttm)-23.55M
Diluted EPS (ttm)-0.11
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)220.98M
Total cash per share (mrq)1.03
Total debt (mrq)9.95M
Total debt/equity (mrq)2.89%
Current ratio (mrq)3.00
Book value per share (mrq)1.61

Cash flow statement

Operating cash flow (ttm)73.48M
Levered free cash flow (ttm)66.65M